On behalf of the Editorial board I invite you to submit your next article to Translational Oncogenomics, an open access electronic journal published by Libertas Academica. The journal specializes in providing wide and open access for high quality genomic scale data related to human cancer etiology, detection, prognosis and treatment. We accept original studies in basic and applied oncogenomics and thoughtful reviews, surveys, opinions, commentaries, techniques, and essays. All submitted articles will be considered and peer-reviewed.
We look forward to receiving your manuscript.
What is the advantage to you of publishing in Translational Oncogenomics?
We look forward to receiving your manuscript.
What is the advantage to you of publishing in Translational Oncogenomics?
- Full open access: everyone can read your article and you retain copyright in it
- Publishing decision within 2 weeks of submission
- Your paper will not be rejected due to lack of space and will be published immediately on acceptance
- Prompt and fair peer review from two expert peer reviewers
- Frequent updates on your paper’s status
- Friendly responsive staff
What a previous author said:
"LA is different, and hopefully represents a kind of scientific publication machinery that removes the hurdles from free flow of scientific thought."
The advantages of a younger journal such as Translational Oncogenomics are numerous but in essence allow us a greater flexibility and responsiveness to authors and readers that older journals cannot match.
Next steps:
- Visit the journal's home page (full open access to all articles)
- Instructions for authors
- Submit a manuscript now (fast 3-step submission process)
- Send me an inquiry
Yours sincerely,
Dr Michael Spinella
Editor-in-Chief
Translational Oncogenomics
Posts
